Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Every time there is positive news,

And then comes the full circle.........How, exactly, is PTSC going to "move onto NASDAQ and attract long term institutional investors" without the I've fulfilled my minimum obligations transparancy that exists today?............It's a catch 22 at this point IMO........

Spinning off PDSG is something I have previously suggested. I don't consider it an issue of fear. What would you consider a fair structure for a PDSG spinoff? How many shares total, how many on the float, and how many to the shareholder, given the present day valuations?..........Unless you're afraid to talk about it?.......

Share
New Message
Please login to post a reply